Relevium Executes LOI to Acquire Montreal Biopharma Contract Manufacturing Company
08 nov. 2019 08h35 HE
|
Relevium Technologies Inc
MONTREAL, Nov. 08, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce it has executed a...
Relevium Technologies Appoints Mark Billings as Chief Financial Officer
07 nov. 2019 09h11 HE
|
Relevium Technologies Inc
MONTREAL, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce the appointment of...
Relevium’s Subsidiary BGX E-Health Secures One Million Dollar Export Contract for the Middle East
30 oct. 2019 09h30 HE
|
Relevium Technologies Inc
MONTREAL, Oct. 30, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that its wholly owned...
Relevium Enters Into LOI to Unlock Value of Wholly Owned Subsidiary BGX E-Health LLC and Announces Conference Call With CEO
29 oct. 2019 09h22 HE
|
Relevium Technologies Inc
MONTREAL, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce On October 25, 2019,...
Relevium Acquires 100% of Late Stage Processing and Medical Sales Applicant Weedsense
17 oct. 2019 08h30 HE
|
Relevium Technologies Inc
MONTREAL, Oct. 17, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce its wholly- owned...
Relevium Enters Into Manufacturing Agreement With Bio V Pharma and Registers 400 NPN Numbers With Health Canada
09 oct. 2019 15h05 HE
|
Relevium Technologies Inc
MONTREAL, Oct. 09, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce today that it has...
Relevium Announces Intention to Spin-Out Pediatric Cannabis Subsidiary Biocannabix
19 sept. 2019 08h34 HE
|
Relevium Technologies Inc
MONTREAL, Sept. 19, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announces its intention to create a new,...
Relevium Announces Results of Annual Meeting of Shareholders and Updates Other Regulatory Matters
11 sept. 2019 09h18 HE
|
Relevium Technologies Inc
MONTREAL, Sept. 11, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce the results of the...
Relevium Announces Record Sales From the Bioganix® Brand and Provides CBD Update
01 août 2019 09h41 HE
|
Relevium Technologies Inc
MONTREAL, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that the company hit...
Relevium Signs Exclusivity Agreement With SOSCannabis.com for Reimbursement for Pediatric Patients
10 juil. 2019 09h30 HE
|
Relevium Technologies Inc
MONTREAL, July 10, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announced today it has executed an...